WEBINAR Patenting Antibodies - Keeping Up With Recent Developments in the Law
Event summary
Developments in the law may jeopardize the validity of patents claiming monoclonal antibodies. This 90-minute webinar will help you understand the following:
- Guidance from the Federal Circuit on the current enablement and written description standards for claiming antibodies
- Strategies and pitfalls in claiming antibody-based compositions of matter
- Implications for method of treatment claims
- Steps every innovator should take before facing competition
For more information, please email Jess Karas.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.